MEANS TO OPTIMIZE THE TREATMENT OF DYSLIPIDEMIA IN PATIENTS WITH HYPOTHYROIDISM
Keywords:hypothyroidism, dyslipidemia, abdominal obesity, atorvastatin
In order to study the peculiarities of lipid metabolism and atorvastatin efficacy for patients with hypothyroidism, it was examined 133 patients with manifested hypothyroidism. It was revealed malfunction lipid metabolism, i. e. a direct correlation between total cholesterol levels and thyroidstimulating hormone (TSH). It was confirmed, that higher indices of dyslipidemia are associated with the most manifested abdominal obesity and with higher body mass index. Reaching of normal levels of thyroid-stimulating hormone during hormone-replacing therapy is not sufficient to gain the required levels of major indices in lipid profile. It was proved efficacy of atorvastatin in complex treatment of hypothyroidism.
Balabolkin MI, Klebanova EM, Kreminskaja VM. Fundamentalnaja i klinicheskaja tiroidologija: rukovodstvo, Moskva, 2007: 816 p.
Goncharova OA. Liky Ukrainy 2011; 6:96-98.
Demidova TYu, Galieva OR. Terapevticheskij Arhiv 2009; 4:69-73.
Kazakov AV, Kravchun NA, Iljina IM, et al. Slovarspravochnik endokrinologa, Harkov, 2009: 682 p.
Malahova SM. Liky Ukrainy 2009; 4:128-130.
Mitchenko EI, Kovalenko VN. Ukr Kardiol Zhurn 2008; 2:45-52.
Mitchenko OI, Lutaj MI. Dyslipidemii: diagnostyka, profilaktyka ta likuvannja: metodychni rekomendatsii, Kiev, 2007: 3, 4, 13-15.
Pankiv VI. Praktychna Tireojidologija, Donetsk,2011: 224 p.